Divergent heparin-induced fibrillation pathways of a prion amyloidogenic determinant

Ehud Bazar, Raz Jelinek

Research output: Contribution to journalArticlepeer-review

24 Scopus citations


Polysaccharides and glycosaminoglycans (GAGs), particularly heparin, have been shown to directly affect fibrillation phenomena and the biological activities of amyloid proteins. We present a systematic analysis of the impact of heparin upon fibrillation of the amyloidogenic determinant of the prion protein PrP(106-126). Experimental data, including thioflavin T fluorescence, transmission electron microscopy, and circular dichroism, demonstrate that heparin induced dramatically diverging aggregation pathways of PrP(106-126). Specifically, enhanced β-sheet formation of the prion fragment leading to fibril assemblies occurred in solutions containing low heparin/prion mole ratios, while mixtures containing a greater abundance of heparin showed almost complete inhibition of PrP(106-126) fibril formation. Based upon the experimental data we have proposed a unified model accounting for the interplay between the roles of heparin as a scaffold for nucleation and fibril growth on the one hand and as a disruptor of fibrillation through electrostatic affinity with the monomeric peptide units on the other. This study clarifies previous conflicting studies, and concludes that GAGs inhibit fibrillation and amyloid toxicity in some cases, and promote amyloidogenesis in others.

Original languageEnglish
Pages (from-to)1997-2002
Number of pages6
Issue number14
StatePublished - 24 Sep 2010


  • Amino acids
  • Amyloid fibrils
  • Amyloid inhibition
  • Circular dichroism
  • Glycosaminoglycans

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Organic Chemistry


Dive into the research topics of 'Divergent heparin-induced fibrillation pathways of a prion amyloidogenic determinant'. Together they form a unique fingerprint.

Cite this